IPO registrations (S-1, F-1) · Registrants
Xtant Medical Holdings, Inc.
- SEC CIK
- 1453593 · filings on EDGAR ↗
- Former names
- Bacterin International Holdings, Inc. (2010–2015); K KITZ INC (2009–2010)
- Registration
- Form S-1, first filed 2009-04-06, last 2025-05-12; 10 initial registrations, 20 amendments
- Outcome
- Final prospectus filed 2016-10-31; declared effective 2009-09-29
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 664 CRUISER LANE, Belgrade, MT 59714
- EIN
- 20-5313323
- Ticker
- XTNT (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Xtant Medical Holdings, Inc. on the corporate pages
On this site
- Business registration: XTANT MEDICAL HOLDINGS INC. Fuzzy (name and state)
- Federal award recipient: XTANT MEDICAL HOLDINGS, INC. Fuzzy (name and state)
- Form D issuer: Xtant Medical Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: Bacterin International Holdings, Inc. EXACT (CIK (EXACT))
Filings 68
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2009-04-06 | S-1 | S-1 (registration) | K KITZ INC | 0001144204-09-019120 ↗ |
| 2009-06-17 | S-1/A | S-1/A (amendment) | K KITZ INC | 0001144204-09-033048 ↗ |
| 2009-08-21 | S-1/A | S-1/A (amendment) | K KITZ INC | 0001144204-09-045148 ↗ |
| 2009-09-18 | S-1/A | S-1/A (amendment) | K KITZ INC | 0001144204-09-049050 ↗ |
| 2009-09-25 | S-1/A | S-1/A (amendment) | K KITZ INC | 0001144204-09-049923 ↗ |
| 2009-09-29 | EFFECT | EFFECT (declared effective) | K KITZ INC | 9999999995-09-002690 ↗ |
| 2010-09-28 | S-1 | S-1 (registration) | Bacterin International Holdings, Inc. | 0001144204-10-051333 ↗ |
| 2010-12-07 | S-1/A | S-1/A (amendment) | Bacterin International Holdings, Inc. | 0001144204-10-065261 ↗ |
| 2011-01-07 | S-1/A | S-1/A (amendment) | Bacterin International Holdings, Inc. | 0001144204-11-001298 ↗ |
| 2011-02-03 | S-1/A | S-1/A (amendment) | Bacterin International Holdings, Inc. | 0001144204-11-005824 ↗ |
| 2011-02-09 | S-1/A | S-1/A (amendment) | Bacterin International Holdings, Inc. | 0001144204-11-006825 ↗ |
| 2011-02-09 | S-1/A | S-1/A (amendment) | Bacterin International Holdings, Inc. | 0001144204-11-007051 ↗ |
| 2011-02-10 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-11-000401 ↗ |
| 2011-05-11 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-11-001478 ↗ |
| 2011-07-14 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-11-002126 ↗ |
| 2011-07-19 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-11-002187 ↗ |
| 2013-07-15 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-13-002081 ↗ |
| 2013-07-24 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-13-002188 ↗ |
| 2014-04-08 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-14-000909 ↗ |
| 2015-04-17 | S-1 | S-1 (registration) | Bacterin International Holdings, Inc. | 0001144204-15-023566 ↗ |
| 2015-04-27 | EFFECT | EFFECT (declared effective) | Bacterin International Holdings, Inc. | 9999999995-15-001024 ↗ |
| 2015-09-08 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-15-002461 ↗ |
| 2015-12-21 | S-1 | S-1 (registration) | Xtant Medical Holdings, Inc. | 0001144204-15-071989 ↗ |
| 2016-05-02 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-16-098354 ↗ |
| 2016-06-08 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-16-107545 ↗ |
| 2016-06-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-16-004886 ↗ |
| 2016-07-07 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-16-005096 ↗ |
| 2016-08-26 | S-1 | S-1 (registration) | Xtant Medical Holdings, Inc. | 0001144204-16-121517 ↗ |
| 2016-09-28 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-16-125750 ↗ |
| 2016-10-06 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-16-127172 ↗ |
| 2016-10-17 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-16-128356 ↗ |
| 2016-10-21 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-16-128907 ↗ |
| 2016-10-28 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-16-130161 ↗ |
| 2016-10-31 | 424B4 | 424B4 (final prospectus) | Xtant Medical Holdings, Inc. | 0001144204-16-130567 ↗ |
| 2016-10-31 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-16-006106 ↗ |
| 2016-11-21 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-16-006283 ↗ |
| 2018-02-07 | S-1 | S-1 (registration) | Xtant Medical Holdings, Inc. | 0001144204-18-006371 ↗ |
| 2018-04-18 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-18-021010 ↗ |
| 2018-04-27 | 424B1 | 424B1 (final prospectus) | Xtant Medical Holdings, Inc. | 0001144204-18-023189 ↗ |
| 2018-04-27 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-18-000955 ↗ |
| 2018-05-15 | S-1 | S-1 (registration) | Xtant Medical Holdings, Inc. | 0001144204-18-028900 ↗ |
| 2018-05-16 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-18-029220 ↗ |
| 2018-05-30 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001144204-18-031665 ↗ |
| 2018-06-04 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-18-001404 ↗ |
| 2020-09-11 | S-1 | S-1 (registration) | Xtant Medical Holdings, Inc. | 0001493152-20-017658 ↗ |
| 2020-10-30 | S-1/A | S-1/A (amendment) | Xtant Medical Holdings, Inc. | 0001493152-20-020239 ↗ |
| 2020-11-03 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-20-003071 ↗ |
| 2020-12-18 | S-1 | S-1 (registration) | Xtant Medical Holdings, Inc. | 0001493152-20-023953 ↗ |
| 2020-12-23 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-20-003665 ↗ |
| 2021-03-03 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-21-000802 ↗ |
| 2021-04-14 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-21-001435 ↗ |
| 2021-05-18 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-21-001998 ↗ |
| 2022-10-20 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-22-003097 ↗ |
| 2023-07-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-23-002086 ↗ |
| 2024-04-08 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-24-000894 ↗ |
| 2024-09-09 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-24-002756 ↗ |
| 2024-09-11 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-24-002801 ↗ |
| 2025-05-12 | S-1 | S-1 (registration) | Xtant Medical Holdings, Inc. | 0001641172-25-009734 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001518 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001522 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001525 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001528 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001530 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001532 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001535 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001536 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001542 ↗ |
| 2025-05-19 | EFFECT | EFFECT (declared effective) | Xtant Medical Holdings, Inc. | 9999999995-25-001659 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| COOK GUY S | Director,Officer,TenPercentOwner; TenPercentOwner | CEO | 51 | 2011–2014 | |
| GANDOLFO JOHN P | Officer | CFO; CFO and Interim Co-CEO | 7 | 2011–2014 | |
| Godfrey Mitchell T | Director | 12 | 2011–2013 | ||
| HERNANDEZ JESUS | Officer | Vice President - Biologics | 1 | 2011 | |
| HOLMES DARREL LEE | Officer | Chief Operating Officer; COO; COO and Interim Co-CEO; Vice President-Medical Devices | 11 | 2011–2014 | |
| LOPACH MICHAEL A | Director | 11 | 2011–2017 | ||
| Swanson Kent L | Director | 16 | 2011–2017 | ||
| WICKWIRE JON M. | Director; Other | 13 | 2011–2016 | ||
| Taggart Robert Jr | Officer | Vice President National Sales | 1 | 2011 | |
| NAVARRO NICHOLAS MAXWELL | Officer | National Sales Manager | 4 | 2012–2013 | |
| JUDA GREGORY ALEXANDER | Officer | Chief Scientific Officer | 8 | 2012–2014 | |
| MICHELLE ALLISON COOK TRUST | TenPercentOwner | 1 | 2012 | ||
| STEVEN THOMAS COOK TRUST | TenPercentOwner | 1 | 2012 | ||
| TIMOTHY SHANE COOK TRUST | TenPercentOwner | 1 | 2012 | ||
| DEEDRICK JOHN ARTHUR | Director | 7 | 2012–2017 | ||
| Goldberger Daniel S | Director,Officer | Chief Executive Officer; President and CEO | 11 | 2013–2016 | |
| DI SILVIO ROBERT M | Officer | President | 1 | 2014 | |
| Goodman David | Director; Other | 4 | 2014–2016 | ||
| Kirschman David Louis | Director,Officer,TenPercentOwner; Director,TenPercentOwner | EVP & Chief Scientific Officer | 5 | 2015–2016 | |
| Brian J. Hemmelgarn Revocable Living Trust dated February 9, 1998, as amended | TenPercentOwner | 1 | 2015 | ||
| Hemmelgarn Brian J. | TenPercentOwner | 1 | 2015 | ||
| Hemmelgarn Kenneth J. Jr. | TenPercentOwner | 1 | 2015 | ||
| Kenneth J. Hemmelgarn, Jr. Revocable Living Trust dated February 9, 1998, as amended | TenPercentOwner | 1 | 2015 | ||
| BUCKMAN PAUL | Director | 3 | 2016–2017 | ||
| Mazzocchi Rudy A | Director | 3 | 2016–2017 | ||
| TIMKO ERIC BERNARD | Director | 3 | 2016–2017 | ||
| O'Connell Carl | Officer | Chief Executive Officer; President | 3 | 2016–2018 | |
| ISALY SAMUEL D | TenPercentOwner | 1 | 2018 | ||
| ORBIMED ADVISORS LLC | Director,TenPercentOwner; TenPercentOwner | 12 | 2018–2025 | ||
| BAKEWELL JOHN K | Director | 11 | 2018–2026 | ||
| Eggenberg Michael | Director; Director,TenPercentOwner | 11 | 2018–2022 | ||
| Mainelli Michael | Director; Director,Officer | Interim CEO | 3 | 2018 | |
| McNamara Robert | Director | 8 | 2018–2024 | ||
| Peters Jeffrey J | Director | 6 | 2018–2022 | ||
| Rizzo Matthew | Director; Director,TenPercentOwner | 11 | 2018–2022 | ||
| Brandt Kevin D | Officer | Chief Commercial Officer; VP & Chief Commercial Officer | 11 | 2018–2024 | |
| Lenzen Kathie J. | Officer | Chief Financial Officer; SVP Fiance & Admin. & CFO | 2 | 2018 | |
| Berlin Ronald G. | Officer | VP & Chief Operations Officer | 2 | 2019 | |
| JENSEN GREG | Officer | Vice President, Finance & CFO; VP, Finance and CFO; VP, Finance and Interim CFO; VP, Finance & CFO | 4 | 2019–2021 | |
| Orbimed ROF II LLC | Director,TenPercentOwner; TenPercentOwner | 9 | 2019–2025 | ||
| Browne Sean E | Director,Officer; Officer | President and CEO; President and Chief Executive | 14 | 2019–2026 | |
| Neils Scott C | Officer | CFO; CFO and Assistant Secretary; Chief Financial Officer; Interim CFO; Interim Chief Financial Office | 13 | 2022–2026 | |
| Vizirgianakis Stavros G. | Director | 8 | 2022–2026 | ||
| Schallenberger Mark A. | Officer | Chief Operating Officer; Chief Operations Officer | 8 | 2023–2026 | |
| Beeson Jonn R. | Director | 6 | 2023–2026 | ||
| MITCHELL-KELLER LORI D | Director | 4 | 2023–2024 | ||
| Harkey Wilmot B. | TenPercentOwner | 1 | 2025 | ||
| Mack Daniel | TenPercentOwner | 1 | 2025 | ||
| Nantahala Capital Management, LLC | TenPercentOwner | 1 | 2025 | ||
| Nantahala Capital Partners Limited Partnership | TenPercentOwner | 1 | 2025 | ||
| JAIN ABHINAV | Director | 3 | 2025–2026 | ||
| Lipschultz Tyler | Director | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-08-12 | Xtant Medical Holdings, Inc. | Other Health Care | $5,000,000 | $5,000,000 | 5 | 1 |
| 2023-07-12 | Xtant Medical Holdings, Inc. | Other Health Care | $15,000,000 | $15,000,000 | 22 | 1 |
| 2022-08-26 | Xtant Medical Holdings, Inc. | Other Health Care | $9,746,606 | $6,748,951 | 11 | 1 |
| 2021-02-26 | Xtant Medical Holdings, Inc. | Other Health Care | $36,250,002 | $20,000,000 | 1 | 1 |
| 2020-10-05 | Xtant Medical Holdings, Inc. | Other Health Care | $62,882,000 | $62,882,000 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.